Elimite (permethrin) 5% cream is a topical prescription medication specifically formulated to treat scabies infestations. As a synthetic pyrethroid, it works by targeting the nervous systems of mites and their eggs, providing a comprehensive approach to eradication. This medication is recognized by dermatologists and infectious disease specialists as a first-line treatment due to its high efficacy and favorable safety profile when used as directed. Proper application and adherence to treatment protocols are essential for achieving complete resolution of symptoms and preventing reinfestation.

Features

• Contains 5% permethrin as the active pharmaceutical ingredient
• Formulated as a topical cream for direct skin application
• Single-use tube packaging (typically 60g) for complete treatment course
• Prescription-only medication requiring healthcare provider authorization
• Stable emulsion base designed for optimal skin penetration and retention
• Manufactured under strict pharmaceutical quality control standards

Benefits

• Effectively eliminates Sarcoptes scabiei mites through neurotoxic action
• Demonstrates ovicidal activity against mite eggs, preventing recurrence
• Provides rapid relief from intense itching associated with scabies infestation
• Requires single application in most cases, enhancing treatment adherence
• Minimal systemic absorption reduces risk of widespread adverse effects
• Clinically proven to achieve >95% cure rates when properly administered

Common use

Elimite is primarily indicated for the treatment of scabies infestations caused by the mite Sarcoptes scabiei var. hominis. Healthcare providers may also prescribe it off-label for certain ectoparasitic infections including pediculosis (lice infestation) when standard treatments prove ineffective. The medication is suitable for adults and children aged 2 months and older, though special consideration must be given to pediatric populations regarding application surface area and monitoring.

Dosage and direction

Apply a thin layer of Elimite cream to clean, dry skin from the neck down, covering all body surfaces including folds between fingers and toes, under nails, wrists, axillae, and genital areas. Pay particular attention to areas where mite burrows are visible. Leave the medication on for 8-14 hours before thoroughly washing off with soap and water. Most cases require only one application, though healthcare providers may recommend re-treatment after 7-14 days if new burrows or mites appear. For infants and young children, apply to scalp, temples, and forehead while avoiding contact with eyes and mouth.

Precautions

• Use only as prescribed by a qualified healthcare provider
• Avoid contact with eyes, nostrils, mouth, and other mucous membranes
• Do not apply to acutely inflamed or broken skin unless directed by physician
• Wash hands thoroughly after application unless treating hands specifically
• Sexual partners and household members may require simultaneous treatment
• Launder all clothing, bedding, and towels in hot water after treatment
• Monitor for signs of hypersensitivity reaction during and after application

Contraindications

Elimite is contraindicated in patients with known hypersensitivity to permethrin, other synthetic pyrethroids, or any component of the formulation. It should not be used in patients with history of severe allergic reactions to chrysanthemums or ragweed. The safety during pregnancy has not been established through well-controlled studies, though animal reproduction studies have not demonstrated fetal risk. Use during lactation should be carefully considered as permethrin is excreted in breast milk.

Possible side effects

• Transient burning, stinging, or tingling at application site (most common)
• Pruritus, erythema, or mild skin irritation
• Numbness or increased itching temporarily after application
• Rash or skin edema in sensitive individuals
• Rare cases of scalp paresthesia reported
• Extremely rare systemic effects including headache, nausea, or dizziness

Drug interaction

No clinically significant drug interactions have been documented with topical permethrin application. However, patients using other topical medications concurrently should space applications appropriately to avoid potential interactions or reduced efficacy. Consult healthcare provider before using with other neurotoxic agents systemically.

Missed dose

As Elimite is typically administered as a single application, the concept of “missed dose” does not generally apply. If the medication is washed off prematurely before the recommended 8-14 hour exposure period, contact your healthcare provider for guidance regarding reapplication. Do not apply additional medication without medical supervision.

Overdose

Excessive application may lead to increased adverse effects including severe skin irritation, paresthesia, and systemic absorption. Symptoms of overdose may include nausea, headache, muscle weakness, and increased salivation. In case of accidental ingestion, seek immediate medical attention as gastric lavage and symptomatic treatment may be required. Topical overdose should be managed by washing the affected area thoroughly with soap and water.

Storage

Store at controlled room temperature (20-25°C or 68-77°F). Keep tube tightly closed and protected from light. Do not freeze. Keep out of reach of children and pets. Discard any unused medication properly after treatment completion. Do not transfer to other containers.

Disclaimer

This information is provided for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for proper diagnosis and treatment recommendations. Individual results may vary based on specific medical conditions and adherence to treatment protocols. The manufacturer and distributors are not liable for improper use or self-medication.

Reviews

Clinical studies demonstrate Elimite’s efficacy with cure rates exceeding 95% in compliant patients. Dermatologists frequently report positive outcomes, noting its superiority over older scabicides like lindane. Patients typically report significant symptom improvement within 24-48 hours of proper application, though complete resolution of itching may take 2-4 weeks as the inflammatory response subsides. The convenience of single application and minimal systemic exposure make it a preferred choice among both providers and patients compared to alternative treatments.